Standout Papers
Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
Prolonged Interferon-γ Application by Subcutaneous Infusion in Cancer Patients: Differential Response of Serum CD14, Neopterin, and Monocyte HLA Class I and II Antigens
1992
Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents
2007
Depression
2018 Standout
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting
2003
Evaluation of the Extent of Under-Reporting of Serious Adverse Drug Reactions
2004
Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
2002 Standout
Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa
2006
Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits
2017 StandoutNobel
SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis
2000 Standout
Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients
2012
Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study
1999
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Under-Reporting of Adverse Drug Reactions
2006 Standout
Head and neck cancer
2008 Standout
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature
2005
Nicotine replacement therapy for long-term smoking cessation: a meta-analysis
2006
Traumatic brain injury
2000 Standout
Drug-Induced Immune Thrombocytopenia
2007
Surgical treatment of children blinded by Stevens-Johnson syndrome
1999
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient
2001
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
The blind spot in the nicotine replacement therapy literature: Assessment of the double-blind in clinical trials
2004
Nicotine replacement therapy for smoking cessation
2008
Uric Acid Lowering to Prevent Kidney Function Loss in Diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study
2013
Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch
2003
Stevens–Johnson syndrome with sulfasalazine treatment: Report of two cases
2011
Genetic susceptibility–molecular epidemiology of head and neck cancer
2002
Nanosilver as a new generation of nanoproduct in biomedical applications
2010 Standout
A Case of Rofecoxib-Associated Stevens-Johnson Syndrome With Corneal and Conjunctival Changes
2004
The biochemistry and medical significance of the flavonoids
2002 Standout
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Muscle Relaxants for Nonspecific Low Back Pain: A Systematic Review Within the Framework of the Cochrane Collaboration
2003
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Metabolic activation in drug allergies
2001
Gout
2016 Standout
Acne vulgaris
2011 Standout
Drug-Induced Skin, Nail and Hair Disorders
2007
Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis
1999
Severe Eye Complications from Stevens-Johnson Syndrome in a Human Immunodeficiency Virus–Infected Patient in Malawi
2013
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?
1998
Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck
2007
Iatrogenically induced Stevens-Johnson syndrome after a car accident
2010
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing
2006
Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study
1997
HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
2012
Prevention of head and neck cancer: Current status and future prospects
2004
A meta-analysis of acupuncture techniques for smoking cessation
1999
Suppression of spontaneous mutagenesis in human cells by DNA base excision–repair
2000 StandoutNobel
The amniotic membrane in ophthalmology
2004 Standout
Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
1998
Efficacy and safety of desensitization to allopurinol following cutaneous reactions
2001
A marker for Stevens–Johnson syndrome
2004 StandoutNature
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
2000
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Ocular Features and Histopathologic Changes during Follow-up of Toxic Epidermal Necrolysis
2010
An Analysis of the Effectiveness of Interventions Intended to Help People Stop Smoking
1995
Nicotine replacement therapy for smoking cessation
2012 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Elevation of Conjunctival Epithelial CD45INTCD11b+CD16+CD14−Neutrophils in Ocular Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
2013
Fluoxetine versus other types of pharmacotherapy for depression
2013
An Antiviral Soluble Form of the LDL Receptor Induced by Interferon
1993 Science
Acupuncture: Theory, Efficacy, and Practice
2002 Standout
Quality Control by DNA Repair
1999 StandoutScienceNobel
Prevention of toxic epidermal necrolysis by regulatory T cells
2005
Interventions for enhancing medication adherence
2008 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis
2007
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
Diabetic Kidney Disease
2017 Standout
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
CELLULAR RESPONSES TO INTERFERON-γ
1997 Standout
Gout
2021 Standout
Point-of-Care Diagnostics for Global Health
2008 Standout
Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis
2007
Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment
2009 Standout
2013
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation
2002
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Review of Toxic Epidermal Necrolysis
2016
Cutaneous Drug Reactions
2001
Industry sponsorship and research outcome
2017 Standout
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
Quantifying Publication Bias in Meta-Analysis
2017 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Muscle relaxants for non-specific low-back pain
2003
Works of Catherine Paoletti being referenced
[A study of various smoking cessation programs based on close to 1000 volunteers recruited from the general population: 1-month results].
1990
Risk of melanoma following adulthood cancer: A case-control study
2005
A phase I trial with recombinant interferon γ (Roussel UCLAF) in advanced cancer patients
1990
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Smoking Cessation Rates 4 Years after Treatment by Nicotine Gum and Acupuncture
1997
A randomised 2 x 2 factorial design to evaluate different smoking cessation methods.
1992
Effects of CYP2D6 activity and tobacco on larynx cancer risk.
1996
Evaluation of the efficacy, tolerability, and therapeutic profile of fluoxetine versus mianserin in the treatment of depressive disorders in the elderly
1992